Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

NCT06987916 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphoma

Interventions

BIOLOGICAL: ssCART-19

Sponsor

Shanghai Tongji Hospital, Tongji University School of Medicine